Oral tests in contact allergy to para-amino compounds.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001566:Benzocaine / Q000009:adverse effects; D003622:Dapsone; D003877:Dermatitis, Contact / Q000175:diagnosis*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010655:Phenylenediamines / Q000009:adverse effects; D012439:Saccharin; D012882:Skin Tests / Q000379:methods*; D013424:Sulfanilamides / Q000009:adverse effects; D012460:Sulfasalazine; D013453:Sulfonylurea Compounds
D010655:Phenylenediamines; D013424:Sulfanilamides; D013453:Sulfonylurea Compounds; D012460:Sulfasalazine; D003622:Dapsone; D012439:Saccharin; D001566:Benzocaine; C029728:4-phenylenediamine